Currenc Group, Inc. (CURR)

USD 1.41

(-0.28%)

Inventory Summary of Currenc Group, Inc.

  • Currenc Group, Inc.'s latest annual inventory in 2023 was 732.91 Thousand USD , up 405.46% from previous year.
  • Currenc Group, Inc.'s latest quarterly inventory in 2024 Q2 was 151 Thousand USD , down -11.18% from previous quarter.
  • Currenc Group, Inc. reported annual inventory of 145 Thousand USD in 2022, down -83.22% from previous year.
  • Currenc Group, Inc. reported annual inventory of 864 Thousand USD in 2021, up 92.43% from previous year.
  • Currenc Group, Inc. reported quarterly inventory of 170 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • Currenc Group, Inc. reported quarterly inventory of 732.91 Thousand USD for 2023 FY, up 405.46% from previous quarter.

Annual Inventory Chart of Currenc Group, Inc. (2023 - 2014)

Historical Annual Inventory of Currenc Group, Inc. (2023 - 2014)

Year Inventory Inventory Growth
2023 732.91 Thousand USD 405.46%
2022 145 Thousand USD -83.22%
2021 864 Thousand USD 92.43%
2020 449 Thousand USD 187.82%
2019 156 Thousand USD 312.96%
2018 37.77 Thousand USD -16.05%
2017 44.99 Thousand USD -44.64%
2016 81.28 Thousand USD -57.55%
2015 191.46 Thousand USD 7.28%
2014 178.48 Thousand USD 0.0%

Peer Inventory Comparison of Currenc Group, Inc.

Name Inventory Inventory Difference
ANI Pharmaceuticals, Inc. 111.19 Million USD 99.341%
Aquestive Therapeutics, Inc. 6.76 Million USD 89.173%
Collegium Pharmaceutical, Inc. 32.33 Million USD 97.733%
Cosmos Health Inc. 4.78 Million USD 84.696%
Cyclo Therapeutics, Inc. 254.35 Thousand USD -188.148%
Esperion Therapeutics, Inc. 65.62 Million USD 98.883%
Cronos Group Inc. 30.33 Million USD 97.584%
Incannex Healthcare Limited -10.01 Million USD 107.318%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Lifecore Biomedical, Inc. 39.97 Million USD 98.167%
Regencell Bioscience Holdings Limited -152.77 Thousand USD 579.723%
Sunshine Biopharma, Inc. 5.73 Million USD 87.22%
Sunshine Biopharma, Inc. 5.73 Million USD 87.22%
SCYNEXIS, Inc. - USD -Infinity%
Safety Shot Inc 1.86 Million USD 60.799%
Theratechnologies Inc. 6.06 Million USD 87.918%
Alpha Teknova, Inc. 11.59 Million USD 93.679%
Universe Pharmaceuticals INC 3.34 Million USD 78.078%
Pacira BioSciences, Inc. 104.35 Million USD 99.298%
Sonoma Pharmaceuticals, Inc. 2.71 Million USD 73.045%
Dynavax Technologies Corporation 53.29 Million USD 98.625%
Ironwood Pharmaceuticals, Inc. 1.00 USD -73291000.0%
Radius Health, Inc. 278.64 Million USD 99.737%
China SXT Pharmaceuticals, Inc. 809.75 Thousand USD 9.49%
Alvotech 74.43 Million USD 99.015%
Intra-Cellular Therapies, Inc. 11.64 Million USD 93.707%
SIGA Technologies, Inc. 64.21 Million USD 98.859%
Shineco, Inc. 1.58 Million USD 53.862%
Silver Spike Investment Corp. - USD -Infinity%
Journey Medical Corporation 10.2 Million USD 92.819%
Petros Pharmaceuticals, Inc. 1.61 Million USD 54.489%
Embecta Corp. 152.1 Million USD 99.518%
Harrow Health, Inc. 10.86 Million USD 93.256%
Procaps Group, S.A. 96.83 Million USD 99.243%
Biofrontera Inc. 10.9 Million USD 93.281%
DURECT Corporation 2.21 Million USD 66.971%
PainReform Ltd. - USD -Infinity%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 99.053%
OptiNose, Inc. 8.05 Million USD 90.898%
RedHill Biopharma Ltd. 5.69 Million USD 87.14%
Organogenesis Holdings Inc. 28.25 Million USD 97.406%
Cumberland Pharmaceuticals Inc. 4.6 Million USD 84.1%
ProPhase Labs, Inc. 3.84 Million USD 80.919%
Phibro Animal Health Corporation 265.91 Million USD 99.724%
Procaps Group S.A. 96.83 Million USD 99.243%
TherapeuticsMD, Inc. - USD -Infinity%
Viatris Inc. 3.46 Billion USD 99.979%
Rockwell Medical, Inc. 5.87 Million USD 87.516%
Aytu BioPharma, Inc. 12.63 Million USD 94.198%
Tilray Brands, Inc. 252.08 Million USD 99.709%
PetIQ, Inc. 159.3 Million USD 99.54%
Talphera, Inc. - USD -Infinity%
Neurocrine Biosciences, Inc. 38.3 Million USD 98.086%
Alimera Sciences, Inc. 1.87 Million USD 60.995%
Assertio Holdings, Inc. 37.68 Million USD 98.055%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Avadel Pharmaceuticals plc 10.38 Million USD 92.939%
Hempacco Co., Inc. 2.54 Million USD 71.175%
Alvotech 74.43 Million USD 99.015%
Lantheus Holdings, Inc. 64.02 Million USD 98.855%
Kamada Ltd. 87.74 Million USD 99.165%
Indivior PLC 141.79 Million USD 99.483%
Evoke Pharma, Inc. 481.84 Thousand USD -52.107%
Flora Growth Corp. 8.5 Million USD 91.386%
Cyclo Therapeutics, Inc. 254.35 Thousand USD -188.148%
Evolus, Inc. 10.99 Million USD 93.336%
HUTCHMED (China) Limited 50.25 Million USD 98.542%
Amphastar Pharmaceuticals, Inc. 105.83 Million USD 99.307%
Akanda Corp. 1.28 Million USD 43.048%